Bolt Biotherapeutics Inc
NASDAQ:BOLT
| Market Cap (Intraday) | 566.60M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | N/A |
| 50-Day MA | N/A |
| 200-Day MA | N/A |
Bolt Biotherapeutics Inc Stock, NASDAQ:BOLT
900 Chesapeake Drive, Redwood City, California 94063
United States of America
Phone: +1.650.665.9295
Number of Employees: 65
Description
Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.